Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
INHIBIDORES DE CINASAS DE AMPLIO ESPECTRO: SORAFENIB (NEXAVAR) Y SUNITINIB (SUTENT) Estos nuevos frmacos tienen la capacidad de inhibir varias vas que permiten la perpetuacin del crecimiento tumoral
Priority Applications (3) Applications Claiming Priority (4) Publications (1) Family ID=50100453 Family Applications (1) Country Status (5) Cited By (2) Families Citing this family (3) Citations (3) 2013 2013-09-27 WO PCT/US2013/062199 patent/WO2014052766A1/en not_active Ceased 2013-09-27 US US14/038,973 patent/US9051351B2/en active Active 2015 2015-03-26 SA SA515360200A patent/SA515360200B1/en unknown 2015-03-26 IL IL237966A patent/IL237966A0/en unknown 2015-04-14 ZA ZA2015/02504A patent/ZA201502504B/en unknown
The growing success of GLP-1 receptor agonists has opened the door to peptide-based therapies for a new group of clinicians, but responsible, evidence-informed practice is what will carry the field forward
Aging signaling pathways and circadian clock-dependent metabolic derangements
doi: 10.1186/s12937-019-0475-x
US$ 21.83
US$ 20.59
US$ 23.48
US$ 26.00
US$ 25.63
US$ 21.23
